SPBC18E5.08 Antibody

What is SPBC18E5.08 and why is it studied in research settings?

SPBC18E5.08 is an uncharacterized N-acetyltransferase (EC 2.3.1.-) from Schizosaccharomyces pombe (strain 972/24843) with a molecular weight of approximately 21,149 Da. It belongs to the family of N-acetyltransferases, which typically catalyze the transfer of acetyl groups from acetyl-CoA to various substrates. Studying this protein contributes to our understanding of post-translational modifications and metabolic pathways in eukaryotic cells, particularly in model organisms like fission yeast. The protein's function remains largely uncharacterized, making it an interesting target for researchers investigating novel enzymatic activities and cellular processes. The availability of specific antibodies enables researchers to track its expression, localization, and potential modifications across different experimental conditions .

What validation methods should be used to confirm SPBC18E5.08 antibody specificity?

Validating antibody specificity is crucial for ensuring reliable experimental results. For SPBC18E5.08 antibody, several complementary approaches are recommended:

• Western blot analysis with both positive controls (wild-type S. pombe lysate) and negative controls (knockout strains or unrelated yeast species)

• Peptide competition assays, where pre-incubation with the immunizing recombinant protein should abolish signal

• Immunoprecipitation followed by mass spectrometry to confirm the identity of the captured protein

• Testing different sample preparation methods to ensure optimal epitope exposure

• Cross-validation with other antibodies or tagged protein constructs where available

The polyclonal nature of the available anti-SPBC18E5.08 antibody means it likely recognizes multiple epitopes on the target protein, which can enhance detection sensitivity but may also increase the risk of cross-reactivity .

What applications is SPBC18E5.08 antibody suitable for?

The SPBC18E5.08 antibody has been validated for the following research applications:

For Western blotting, the antibody should detect a band corresponding to the predicted molecular weight of 21,149 Da. The non-conjugated, liquid formulation contains 50% glycerol and 0.03% Proclin 300 as preservatives in a 0.01M PBS buffer (pH 7.4), making it stable for laboratory use. For optimal results, samples should be fully denatured to expose the epitopes recognized by this polyclonal antibody .

How should SPBC18E5.08 antibody be stored and handled?

Proper storage and handling are essential for maintaining antibody functionality:

• Upon receipt, store the antibody at -20°C or -80°C to maintain activity

• Avoid repeated freeze-thaw cycles by aliquoting the antibody into smaller volumes before freezing

• If small volumes become entrapped in the vial seal during shipment, briefly centrifuge the vial to collect the liquid

• For short-term use, the antibody can be stored at 4°C for up to one month

• Before use, allow the antibody to equilibrate to room temperature and gently mix

• Avoid contamination by using sterile pipette tips and tubes

The presence of 50% glycerol in the formulation helps prevent damage during freeze-thaw cycles, but minimizing these cycles is still recommended for optimal performance .

What controls should be included in experiments using SPBC18E5.08 antibody?

When designing experiments with SPBC18E5.08 antibody, include the following controls:

• Positive control: Wild-type S. pombe lysate expressing endogenous SPBC18E5.08

• Negative control: Lysate from SPBC18E5.08 knockout strain or unrelated yeast species

• Loading control: Detection of housekeeping proteins (e.g., actin, GAPDH) to normalize sample loading

• Isotype control: Non-specific rabbit IgG at the same concentration to identify non-specific binding

• Secondary antibody only: Omitting primary antibody to assess background signal

• Antigen competition: Pre-incubating the antibody with excess recombinant SPBC18E5.08 protein

These controls help validate experimental results by distinguishing specific signals from background and confirming the identity of detected proteins. For quantitative applications, including a standard curve with known quantities of purified protein can provide a reference for determining relative expression levels .

How can epitope mapping be performed for SPBC18E5.08 antibody?

Epitope mapping for SPBC18E5.08 antibody involves several complementary approaches:

• Peptide array analysis:

  • Synthesize overlapping peptides (15-20 amino acids) spanning the entire SPBC18E5.08 sequence

  • Immobilize peptides on membranes or glass slides

  • Probe with the antibody to identify reactive regions

  • Narrow down the epitope through alanine scanning mutagenesis

• Recombinant fragment analysis:

  • Generate truncated versions of SPBC18E5.08 protein

  • Express in bacterial or yeast systems

  • Test antibody reactivity against each fragment by Western blot

  • Identify the minimal region required for antibody recognition

This approach is particularly valuable as it mimics the strategy used in the study of SpA5 antibodies, where synthetic peptides corresponding to predicted epitopes (e.g., N847-S857) were used to validate antibody binding sites. The identified epitopes can then be used in competitive binding assays to confirm specificity .

What strategies can improve Western blot detection sensitivity with SPBC18E5.08 antibody?

Enhancing Western blot sensitivity requires optimization at multiple steps:

These strategies can collectively improve the signal-to-noise ratio, potentially allowing detection of SPBC18E5.08 even when expressed at low levels .

How can SPBC18E5.08 antibody be used to investigate protein-protein interactions?

Several approaches can leverage SPBC18E5.08 antibody for protein interaction studies:

• Co-immunoprecipitation (Co-IP):

  • Lyse S. pombe cells under non-denaturing conditions

  • Immobilize SPBC18E5.08 antibody on protein A/G beads

  • Capture SPBC18E5.08 along with interacting proteins

  • Identify binding partners by mass spectrometry or Western blot

• Proximity labeling:

  • Generate SPBC18E5.08 fusion with BioID or APEX2

  • Allow biotinylation of proximal proteins in living cells

  • Verify SPBC18E5.08 expression using the antibody

  • Capture biotinylated proteins with streptavidin

  • Identify interaction partners by mass spectrometry

This methodological approach parallels techniques used in researching antibody-antigen interactions, such as those employed in the study of Abs-9 antibody against SpA5, where co-incubation experiments followed by protein A bead binding and mass spectrometry were used to confirm specific antigen targeting .

What considerations are important for immunoprecipitation-mass spectrometry (IP-MS) with SPBC18E5.08 antibody?

For successful IP-MS experiments using SPBC18E5.08 antibody, consider the following parameters:

Similar approaches have been successfully employed in antibody research, as seen in the characterization of Abs-9, where immunoprecipitation followed by mass spectrometry confirmed that SpA5 was the specific antigen targeted by the antibody .

How can post-translational modifications of SPBC18E5.08 be studied using this antibody?

Investigating post-translational modifications (PTMs) requires specialized techniques:

• Phosphorylation analysis:

  • Immunoprecipitate SPBC18E5.08 under native conditions

  • Analyze by Western blot with phospho-specific antibodies

  • Alternatively, use Phos-tag SDS-PAGE to separate phosphorylated forms

  • For site identification, perform IP-MS with phosphopeptide enrichment

• Acetylation studies:

  • Immunoprecipitate SPBC18E5.08 under conditions that preserve acetylation

  • Probe with anti-acetyllysine antibodies

  • Include HDAC inhibitors during sample preparation

  • For comprehensive analysis, perform IP-MS with acetylpeptide enrichment

• Ubiquitination detection:

  • Use denaturing conditions to disrupt protein-protein interactions

  • Probe immunoprecipitates with anti-ubiquitin antibodies

  • For site identification, look for the characteristic K-ε-GG remnant after trypsin digestion

These approaches are particularly relevant for studying N-acetyltransferases like SPBC18E5.08, as these enzymes are themselves often regulated by PTMs and studying these modifications can provide insights into enzyme regulation and function .

What are common issues when using SPBC18E5.08 antibody and how can they be resolved?

These troubleshooting approaches are similar to those used in antibody research generally, where careful optimization is required to achieve specific detection of target antigens .

How can SPBC18E5.08 antibody be used for studying protein localization in yeast cells?

Investigating subcellular localization requires specific protocols:

• Immunofluorescence microscopy:

  • Fix S. pombe cells with formaldehyde or methanol

  • Permeabilize cell walls using enzymatic digestion (zymolyase)

  • Block with BSA or normal serum

  • Incubate with SPBC18E5.08 antibody (typically 1:100-1:500)

  • Detect with fluorophore-conjugated secondary antibodies

  • Co-stain with organelle markers for colocalization studies

• Cellular fractionation:

  • Separate cellular compartments (cytosol, nucleus, membranes)

  • Analyze fractions by Western blot using SPBC18E5.08 antibody

  • Include markers for each subcellular compartment as controls

This approach is conceptually similar to methods used to study antibody localization in infection models, where careful fixation and detection protocols are essential for preserving epitope accessibility and achieving specific staining .

How can quantitative analysis be performed using SPBC18E5.08 antibody?

For quantitative applications:

• Western blot quantification:

  • Include a standard curve using recombinant SPBC18E5.08

  • Use fluorescent secondary antibodies for wider dynamic range

  • Normalize to loading controls (actin, GAPDH)

  • Analyze using image analysis software with background subtraction

• ELISA development:

  • Coat plates with recombinant SPBC18E5.08 or anti-SPBC18E5.08

  • Develop standard sandwich or competitive ELISA formats

  • Validate assay for linearity, specificity, and reproducibility

  • Use for high-throughput quantification across multiple samples

Quantitative approaches allow researchers to measure changes in protein expression under different experimental conditions, similar to how antibody titers are measured in vaccine studies to assess immune response magnitudes .

How can SPBC18E5.08 antibody be used in chromatin immunoprecipitation studies?

If SPBC18E5.08 has DNA-binding or chromatin-associated functions:

• Chromatin immunoprecipitation (ChIP) protocol:

  • Crosslink S. pombe cells with formaldehyde

  • Lyse cells and sonicate to fragment chromatin

  • Immunoprecipitate with SPBC18E5.08 antibody

  • Reverse crosslinking and purify DNA

  • Analyze by qPCR or next-generation sequencing

• ChIP optimization considerations:

  • Crosslinking time and concentration are critical parameters

  • Sonication conditions must be optimized for desired fragment size

  • Include appropriate controls (input, IgG, positive control regions)

  • Consider ChIP-exo or ChIP-nexus for higher resolution

This type of application would be particularly relevant if SPBC18E5.08 is found to play a role in regulating gene expression or chromatin modification, similar to how antibody-based approaches have been used to map binding sites of other regulatory proteins .

What approaches can be used to develop function-blocking antibodies against SPBC18E5.08?

To develop antibodies that inhibit SPBC18E5.08 function:

• Epitope targeting strategy:

  • Identify functional domains through bioinformatics

  • Generate antibodies against catalytic or substrate-binding regions

  • Screen antibodies for functional inhibition in enzymatic assays

• Testing functional blocking:

  • Develop in vitro N-acetyltransferase activity assays

  • Test antibody effects on enzymatic activity

  • Validate in cellular systems through microinjection or cell-permeable antibody derivatives

This approach is conceptually similar to the development of therapeutic antibodies, like Abs-9, which demonstrates prophylactic efficacy against S. aureus by targeting specific functional epitopes of the SpA5 antigen. The identification and targeting of functional epitopes are crucial for developing antibodies with inhibitory properties .

How can SPBC18E5.08 antibody be used in proteomics workflows?

Integrating SPBC18E5.08 antibody into proteomics research:

• Immunoaffinity enrichment:

  • Couple antibody to affinity resins or magnetic beads

  • Enrich SPBC18E5.08 and associated proteins from complex mixtures

  • Analyze enriched fractions using mass spectrometry

  • Identify co-purifying proteins as potential interactors

• Targeted proteomics:

  • Develop multiple reaction monitoring (MRM) or parallel reaction monitoring (PRM) assays

  • Use antibody-based enrichment upstream of targeted MS analysis

  • Quantify SPBC18E5.08 and associated proteins across multiple conditions

These proteomics approaches are similar to methods used in antibody research, where mass spectrometry is employed to identify specific antigens targeted by antibodies, as demonstrated in the study of Abs-9 binding to SpA5 .

What are the key considerations for successful application of SPBC18E5.08 antibody in research?

The successful use of SPBC18E5.08 antibody in research requires:

• Proper validation of antibody specificity using multiple approaches

• Optimization of experimental conditions for each application

• Inclusion of appropriate positive and negative controls

• Consideration of the polyclonal nature of the antibody and potential batch-to-batch variation

• Understanding the limitations of antibody-based detection in different experimental contexts

By addressing these considerations, researchers can maximize the reliability and reproducibility of results obtained using SPBC18E5.08 antibody. As with other antibody-based research tools, careful experimental design and validation are essential for generating meaningful scientific insights.